Sustaining growth momentum is key for Navin Fluorine: ICICI Securities

NFIL’s ambition is to reach revenues of US$100mn from CDMO by FY25.

Kopran acquire assets of Abhinandan Rasayan

Once the unit is made fully functional, it will help the company in increasing its API and intermediate production capacity

ProBioGen co-develops new Freedom ExpiCHO-S cell line development kit

It allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience in the field.

DKSH acquires two ear care brands

DKSH has signed an agreement to acquire two ear care brands from Noru Pharma for Australia, New Zealand, and selected markets in Asia.

Celanese support the sustained-release drug delivery market

Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions

Evonik and Phathom Pharmaceuticals partner to produce novel acid-blocker vonoprazan

Agreement strengthens Evonik’s track record as leading contract development and manufacturing organization (CDMO)

Nureca's subsidiary receives ISO 13485 certification for Indian medical device facility

The certification will open new avenues for our flagship brand “Dr Trust”, enabling them to export these devices to many more countries

Dipharma receives regulatory authorization for the new line at Its cGMP pilot plant

The company increases its efficiency and is able to face the growing demand for its services.

AGC begins study to expand its Bio-CDMO capability in Japan

Shionogi and MPP sign licence agreement for COVID-19 oral antiviral treatment

Ensitrelvir is being evaluated for the treatment of COVID-19 to be administered as an oral tablet formulation taken once daily for five days.